• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Pancreatic Cancer, An Issue of Hematology/Oncology Clinics of North America

Pancreatic Cancer, An Issue of Hematology/Oncology Clinics of North America

9780323986557
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 14 DAYS
483,79 zł
411,22 zł Zniżka 72,57 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 411,22 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DHL, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
In this issue of Hematology/Oncology Clinics, guest editors Drs. Matthew B. Yurgelun and Douglas A. Rubinson bring their considerable expertise to the topic of Pancreatic Cancer. Top experts in the field cover key topics such as pancreatic adenocarcinoma:: trends in epidemiology, risk factors, and outcomes; decision making regarding perioperative therapy in individuals with localized pancreatic adenocarcinoma; the evolving role of radiotherapy in the management of individuals with pancreatic adenocarcinoma; and more.
Szczegóły produktu
Elsevier
94144
9780323986557
9780323986557

Opis

Rok wydania
2022
Numer wydania
1
Oprawa
twarda
Liczba stron
240
Wymiary (mm)
152 x 229
Waga (g)
450
  • Pancreatic Adenocarcinoma: Trends in Epidemiology, Risk Factors, and OutcomesThe Interplay Among Pancreatic Cancer, Cachexia, Body Composition, and DiabetesWhat Can We Learn About Pancreatic Adenocarcinoma from Imaging?Screening and Surveillance for Pancreatic Adenocarcinoma in High-Risk IndividualsGermline Testing for Individuals with Pancreatic Adenocarcinoma and Novel Genetic Risk FactorsDecision-Making Regarding Perioperative Therapy in Individuals with Localized Pancreatic AdenocarcinomaNovel Considerations in Surgical Management of Individuals with Pancreatic AdenocarcinomaRadiotherapy for Pancreatic Adenocarcinoma: Recent Developments and Advances on the HorizonCytotoxic Chemotherapy in Advanced Pancreatic CancerPARPis and Other Novel, Targeted Therapeutics in Pancreatic AdenocarcinomaGenetics of Pancreatic Neuroendocrine TumorsPalliative and Supportive Care for Individuals with Pancreatic Adenocarcinoma
Komentarze (0)